Amy Beckley, Ph.D.

Founder and CEO of Proov

Amy Beckley, Ph.D., created Proov after her battle with infertility and recurrent miscarriages (seven total) led her to discover the cause, which was low progesterone after ovulation. She has a Ph.D. in Pharmacology from the University of Colorado and an MBA from Kansas State University. She studied breast cancer progression, stress signaling, and vaccine development, but her passion to change the way infertility is diagnosed and treated was developed after her personal experience. Dr. Beckley created an innovative hormone testing platform that empowers women with information regarding their own fertility so they can advocate for themselves and get better care. Proov is dedicated to empowering women at every stage of life to track their own hormones quickly and easily at home. Dr. Beckley lives in Boulder, CO with her two kids (one born via in vitro fertilization and one natural progesterone miracle), her husband, a boy named Fozzy, a Russian Tortoise named Lazy, and a Chinchilla named Dash.

1:45-2:45 p.m.

Thursday October 31,  2024

EY’s Pulse of the Industry—Presentation and Panel Discussion

A comprehensive look at the EY report’s findings with a focus on the trends driving change within the industry. From digital healthcare to regulatory shifts, this overview of the happenings within medtech will help shape expectations of what’s ahead for the sector. Following the presentation, a panel will focus on the points highlighted during the presentation and discuss their impact on the medtech sector. Using the report’s findings as the conversation pathway, this group of industry representatives will reflect on how factors such as digital health and regulatory changes, along with numerous other variables, will play a role in shaping healthcare technology.